Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Choice of PD-L1 immunohistochemistry assay influences clinical eligibility for gastric cancer immunotherapy

PaperCitations, authors & open-access status

Choice of PD-L1 immunohistochemistry assay influences clinical eligibility for gastric cancer immunotherapy is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 109 citations, 2022 year and hybrid oa status.

109
Citations
2022
Year
hybrid
OA Status

Related on ScholarIQ

Benjamin Kye Jyn Tan
Author
Cancer Immunotherapy and Biomarkers
Topic
Cancer Immunotherapy and Biomarkers
Topic
Gastric Cancer Management and Outcomes
Topic
HER2/EGFR in Cancer Research
Topic
470M+ articles · free account